APRIL BLAIR: Open Payments
NPI 1750852364 · HUNTINGTON, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$305 in 20 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $677 · 2025 $305
Food & beverage: $305
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 13 | $184 |
| KYOWA KIRIN, INC. | 1 | $21 |
| Paratek Pharmaceuticals, Inc. | 1 | $20 |
| Novo Nordisk Inc | 1 | $20 |
| Lilly USA, LLC | 1 | $19 |
| ABIOMED | 1 | $14 |
| ABBVIE INC. | 1 | $14 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
Products named: LEQVIO, CRYSVITA, NUZYRA, Ozempic, MOUNJARO, VRAYLAR, JARDIANCE.
Industry payments across WV — which companies pay providers there.
